• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Calviri

Monday, June 03, 2024
CP
Oncology
Calviri is developing products to end cancer worldwide. We have made a fundamental discovery in tumor RNA misprocessing that can provide 1)a preventative cancer vaccine, 2) therapeutic vaccines for early cancer, 3) a diagnostic to detect cancer early. We are just completing a 5 yr, 800 dog clinical trial of our preventative vaccine. It is showing a 60% reduction in cancer in vaccinated dogs. This may be the biggest breakthrough in cancer. We are initiating a clinical trial of our off the shelf therapeutic vaccine and expect to commercialize our diagnostic this year. All our products are affordable to address cancer worldwide. We believe there is a path to end cancer worldwide, with Calviri's products playing a prominent role in the effort.
Calviri
Company Website: http://calviri.com
Lead Product in Development: preventative cancer vaccine and diagnostic for early stage cancer
Number Of Unlicensed Products (For Which You Are Seeking Partners): 3

Company HQ City

Phoenix

Company HQ State

Arizona

Company HQ Country

United States

CEO/Top Company Official

Stephen Albert Johnston

Development Phase of Primary Product

Phase III
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS